1. Home
  2. GDC vs GBIO Comparison

GDC vs GBIO Comparison

Compare GDC & GBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GDC
  • GBIO
  • Stock Information
  • Founded
  • GDC 2015
  • GBIO 2016
  • Country
  • GDC United States
  • GBIO United States
  • Employees
  • GDC N/A
  • GBIO N/A
  • Industry
  • GDC Steel/Iron Ore
  • GBIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • GDC Industrials
  • GBIO Health Care
  • Exchange
  • GDC Nasdaq
  • GBIO Nasdaq
  • Market Cap
  • GDC 29.0M
  • GBIO 29.2M
  • IPO Year
  • GDC N/A
  • GBIO 2020
  • Fundamental
  • Price
  • GDC $3.80
  • GBIO $0.39
  • Analyst Decision
  • GDC
  • GBIO Strong Buy
  • Analyst Count
  • GDC 0
  • GBIO 4
  • Target Price
  • GDC N/A
  • GBIO $7.33
  • AVG Volume (30 Days)
  • GDC 170.3K
  • GBIO 1.1M
  • Earning Date
  • GDC 08-13-2025
  • GBIO 08-06-2025
  • Dividend Yield
  • GDC N/A
  • GBIO N/A
  • EPS Growth
  • GDC N/A
  • GBIO N/A
  • EPS
  • GDC N/A
  • GBIO N/A
  • Revenue
  • GDC N/A
  • GBIO $24,556,000.00
  • Revenue This Year
  • GDC N/A
  • GBIO N/A
  • Revenue Next Year
  • GDC N/A
  • GBIO N/A
  • P/E Ratio
  • GDC N/A
  • GBIO N/A
  • Revenue Growth
  • GDC N/A
  • GBIO 146.47
  • 52 Week Low
  • GDC $1.03
  • GBIO $0.30
  • 52 Week High
  • GDC $12.18
  • GBIO $3.65
  • Technical
  • Relative Strength Index (RSI)
  • GDC 68.42
  • GBIO 52.02
  • Support Level
  • GDC $3.47
  • GBIO $0.32
  • Resistance Level
  • GDC $4.00
  • GBIO $0.36
  • Average True Range (ATR)
  • GDC 0.34
  • GBIO 0.03
  • MACD
  • GDC 0.04
  • GBIO 0.00
  • Stochastic Oscillator
  • GDC 88.79
  • GBIO 81.00

About GDC GD Culture Group Limited

GD Culture Group Ltd focuses its business on two segments mainly through the Company and two subsidiaries. 1) AI-driven digital human creation and customization; 2) Live streaming and e-commerce. The company has relentlessly been focusing on serving its customers and creating value for them through the continual innovation and optimization of its products and services. For the AI-driven digital human creation and customization sector, the Company uses AI algorithms and software to generate realistic 3D or 2D digital human models. AI algorithms and machine learning models are used to simulate human characteristics, such as facial expressions, body movements, and even speech patterns.

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

Share on Social Networks: